PRX 00933

Drug Profile

PRX 00933

Alternative Names: 876167; ALT 933; BVT-933; GW 876167; PRX00933

Latest Information Update: 28 May 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Biovitrum
  • Developer Altacor; Proximagen
  • Class Anorectics; Obesity therapies
  • Mechanism of Action Serotonin 2C receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Glaucoma; Obesity

Most Recent Events

  • 04 Aug 2015 Altacor has been acquired by Esperante Ventures
  • 14 Aug 2012 Proximagen has been acquired by Upsher-Smith
  • 05 Mar 2012 No development reported - Phase-II for Obesity in Sweden (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top